QuarterHawk — Equity ResearchQuarterHawk — Equity Research

Alphatec Holdings, Inc. (ATEC)

Healthcare

Actionable
Fundamental
3
Sentiment
4
Technical
4

Buy limit 10.09 (GTC): pullback_to_support entry at the 10.02-10.09 shelf (EMA9 / 09-17 regular-session low) inside a post-catalyst uptrend; protective stop 9.59 (1.0xATR pullback floor below entry), targets 11.09 and 11.84, R/R 2.00. Breakout stop above the settled 09-16 high 10.76 was evaluated and rejected as inferior (~1.18 R/R).

Analysis as of 2026-09-17· more than 2 trading days ago

Company overview

Alphatec Holdings, Inc. is a medical technology company specializing in surgical solutions for spinal conditions. Its product offerings include systems for nerve injury reduction, spinal fixation, and interbody implants. The company markets its products across the United States through distributors and a direct sales force.

Fundamental

fair
Fundamental3
Mixed fundamentals

Alphatec shows strong growth and improving cash flow but remains highly leveraged with ongoing GAAP losses.

FundamentalScore 3/5 (Mixed): ATEC is growing quickly with strong gross margins and an EBITDA inflection plus improving operating cash flow, but it remains GAAP-unprofitable and highly leveraged versus a thin EBITDA base (net debt/EBITDA ~36x) with a distress-zone Altman Z-score; liquidity is supported by cash and revolving credit and the latest 10-K does not disclose an explicit going-concern warning.

Sentiment

good
Sentiment4
Constructive sentiment

Media sentiment has improved following positive Q2 results, with no significant legal or regulatory issues identified.

ATEC’s 2026-08-04 Q2 results/outlook update (announced) is being received positively, driving bullish media sentiment over the last ~14d (polarity_score +0.43) versus a mixed-to-bearish 30–90d baseline (−0.23). No regulator-confirmed investigations surfaced (only plaintiff-law-firm solicitation alerts); Red-Flag Screen clean.

Technical

good
Technical4
Bullish uptrend

The stock is in a bullish uptrend with a pullback to support, offering a favorable risk/reward setup.

Bullish emerging uptrend: price 10.28 above rising SMA20 (9.61), SMA50 (9.40), EMA9 (10.09), EMA21 (9.77) and the WMA/DEMA/TEMA stack; MACD positive (0.28) above signal (0.15) with positive histogram (0.12), RSI14 58.4, Williams -30.9. Weak signals: ADX14 15.9 (trend still young, below 25) and price below a still-declining SMA200 (12.12), though the MACD line+histogram are positive (confirmed momentum reclaim), so the below-200 read is stale rather than active. The 09-11 catalyst day (+10.8% on 6.46M shares) broke the stock out of an 8.60-9.60 base; the last three sessions (10.66, 10.50, 10.28) are a low-volume pullback toward the 10.02-10.09 support shelf (today's regular-session low 10.02 / EMA9 10.09) inside an intact short-term uptrend. A limit entry into that shelf gives R/R 2.00 against a 1.0xATR-floored stop; a breakout stop above the settled 09-16 high (10.76) was also evaluated and gives only ~1.18 R/R, so the pullback limit is the chosen entry.

You’re looking at 2026-09-17 — more than 2 trading days ago.

Subscribers saw this then, and see today’s score, verdict and trade plan now.

Not financial advice. For informational and educational purposes only.